In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Genevieve S DobihalDepartment of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, NY 10032.
Kristen LewisDepartment of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, NY 10032.
Tian Huai ShenDepartment of Medicine, Division of Nephrology, Columbia University Medical Center, New York, NY 10032.
Carmen M HerreraDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.ORCID 0000-0002-8343-4837 Lisa YuDepartment of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, NY 10032.ORCID 0009-0009-9101-6684 Jonathan BaraschDepartment of Medicine, Division of Nephrology, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0002-6723-9548 M Stephen TrentDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.ORCID 0000-0001-6134-1800 Josué Flores-KimBiochemistry and Molecular Biotechnology Department, UMass Chan Medical School, Worcester, MA 01605.
Anne-Catrin UhlemannDepartment of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, NY 10032.ORCID 0000-0002-9798-4768 Funding
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3MTranscriptional Regulation of Urothelial Differentiation During Homeostasis and Repair in Response to Urinary Tract InfectionU54DK104309 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JONATHAN M. BARASCH, ALI G GHARAVI · 2014 to 2026
$17.7MSynthesis and transport of outer membrane components across the Gram-negative cell envelopeR01AI176776 · NIAID · UNIVERSITY OF GEORGIA · PI Michael Stephen Trent · 2023 to 2026
$2.5MThe role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelopeR01AI174416 · NIAID · UNIVERSITY OF GEORGIA · PI Michael Stephen Trent · 2023 to 2026
$2.4MColumbia Integrated Training Program in Infectious Diseases ResearchT32AI100852 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK, Anne-Catrin Uhlemann · 2013 to 2026
$2.2MDiscovery and characterization of bacterial cell envelope assembly and remodeling networks that modulate tolerance to antibioticsR35GM150669 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Josue Flores-Kim · 2023 to 2026
$1.7MMentoring program in patient-oriented research in microbial genomicsK24AI183182 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Anne-Catrin Uhlemann · 2024 to 2026
$606kHHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) K24AI183182HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI174416HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI176776HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI100852HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) U54DK104309HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM150669NCI NIH HHS P30 CA013696NIAID NIH HHS K24 AI183182NIAID NIH HHS R01 AI174416NIAID NIH HHS R01 AI176776NIAID NIH HHS T32 AI100852NIDDK NIH HHS U54 DK104309NIGMS NIH HHS R35 GM150669
6 · The paper itselfAbstract
Antimicrobial resistance is a severe public health burden. Especially concerning are multidrug resistant (MDR) infections, which restrict treatment options and significantly increase mortality risk. A major cause of MDR infections worldwide is carbapenem-resistant
Indexed as
Fimbriae, BacterialKlebsiella pneumoniaeProtein Processing, Post-TranslationalBacterial ProteinsCarbapenemsDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialKlebsiella InfectionsVirulenceBacterial ProteinsCarbapenemsantimicrobial resistancefimbriaeKlebsiella pneumoniaepathogenesissignaling system
Identifiers
PMID42525513
PMCPMC13419641
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390